These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7531048)

  • 1. [Colony stimulating factors in blood formation].
    Goebel M
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():51-6. PubMed ID: 7531048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Integration of G-CSF in prevention and therapy of neutropenic fever].
    Siegmund R; Illiger HJ
    Med Klin (Munich); 1996 Feb; 91(2):82-8. PubMed ID: 8850103
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical effects of biologic response modifiers.
    Louie SG; Jung B
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S10-8. PubMed ID: 7689788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rational therapy with G-CSF and GM-CSF].
    Link H; Herrmann F; Welte K; Aulitzky WE; Ganser A; Kern WV; Meyer P; Schrappe M; Schmoll HJ; Werdan K
    Med Klin (Munich); 1994 Aug; 89(8):429-41. PubMed ID: 7526144
    [No Abstract]   [Full Text] [Related]  

  • 6. [Growth factors in oncology: effectiveness and prospects].
    Ottmann OG; Hoelzer D
    Praxis (Bern 1994); 1998 Sep; 87(36):1153-9. PubMed ID: 9782744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost considerations in therapy with myeloid growth factors.
    Glaspy JA; Jakway J
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterility of unit dose syringes of filgrastim and sargramostim.
    Singh RF; Corelli RL; Guglielmo BJ
    Am J Hosp Pharm; 1994 Nov; 51(22):2811-2. PubMed ID: 7531941
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug formulary review process for sargramostim and filgrastim: focus on analysis of adverse drug reactions.
    Kellihan MJ
    Clin Ther; 1993; 15(5):927-37. PubMed ID: 7505717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients.
    Page B; Morin MP; Mamzer MF; Thervet E; Legendre C
    Transplant Proc; 1994 Feb; 26(1):283. PubMed ID: 8108982
    [No Abstract]   [Full Text] [Related]  

  • 12. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 13. Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine.
    Fernández-Varón E; Villamayor L
    Vet J; 2007 Jul; 174(1):33-41. PubMed ID: 17029990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor: key (f)actor or innocent bystander in the development of secondary myeloid malignancy?
    Touw IP; Bontenbal M
    J Natl Cancer Inst; 2007 Feb; 99(3):183-6. PubMed ID: 17284707
    [No Abstract]   [Full Text] [Related]  

  • 15. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].
    Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M
    Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397
    [No Abstract]   [Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.
    Sung L; Nathan PC; Lange B; Beyene J; Buchanan GR
    J Clin Oncol; 2004 Aug; 22(16):3350-6. PubMed ID: 15310780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [First experience with the use of granulocyte-macrophage colony stimulating factor in pediatric oncology].
    Ferencz T; Csáki C; Koós R; Schuler D; Borsi J
    Orv Hetil; 1993 Jul; 134(27):1469-73. PubMed ID: 8351131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential use of G-CSF and GM-CSF after heart-lung transplantation.
    Ippoliti G; Negri M; Rovati B; Grossi P; Viganó M
    J Heart Lung Transplant; 1997 Apr; 16(4):473-5. PubMed ID: 9154962
    [No Abstract]   [Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T
    AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.